These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 13714806)

  • 21. [Clinical study on the combined action of a neuroleptic and antiparkinson drug].
    LAUNAY J; RUDRAUF J; CHALLOU C
    Ann Med Psychol (Paris); 1961 Jun; 119(2)():185-96. PubMed ID: 13759475
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of ambutonium bromide in the management of gastrointestinal disease.
    ROSSMAN M
    Am J Gastroenterol; 1960 Oct; 34():414-8. PubMed ID: 13743751
    [No Abstract]   [Full Text] [Related]  

  • 23. Combined oxyphencyclimine-hydroxyzine therapy in gastroenterologic disorders.
    HOCK CW
    Am J Gastroenterol; 1960 Sep; 34():293-8. PubMed ID: 14402207
    [No Abstract]   [Full Text] [Related]  

  • 24. Bentyl with quiactin in gastroenterology.
    HOCK CW
    J Med Assoc Ga; 1959 Nov; 48():555-7. PubMed ID: 14402204
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical trial in peptic ulceration of "stelabid", a combination of trifluoperazine (stelazine) and isopropamide iodine (tyrimide).
    ARDEN LD
    J R Nav Med Serv; 1960; 46():30-3. PubMed ID: 13794112
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical trials of RP 6549 (theralene) in functional digestive disorders].
    MILSTEIN J
    Sem Med Prof Med Soc; 1959 Jan; 35():102-5. PubMed ID: 14422694
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical study on the combined action of orphenadrine and thioproperazine: correction of neuroleptic impregnation and therapeutic synergism].
    RUDRAUF J; CHALLOU C
    Acta Neurol Psychiatr Belg; 1961 Jan; 61():103-9. PubMed ID: 13744502
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessment of a new antiparkinson drug (UK-738) in the thioperazine-in-duced extrapyramidal reaction.
    MANDEL W; CLAFFEY B; MARGOLIS LH
    Dis Nerv Syst; 1961 Oct; 22():571-3. PubMed ID: 14469189
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of gastroduodenal peptic ulcer with the combination of clidinium bromide and chlordiazepoxide. Preliminary note].
    NAGLE GJ
    Hospital (Rio J); 1962 May; 61():977-80. PubMed ID: 14477958
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anticholinergic agents].
    MEEROFF M
    Prensa Med Argent; 1961 Apr; 48():1277-87. PubMed ID: 14472076
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experiments with a new antispasmodic agent MTS 263 in gastroenterology and internal medicine].
    DUBARRY JJ; TOURNERIE J; BERNARD JP; MARQUE J
    Gaz Med Fr; 1962 Feb; 69():485-7. PubMed ID: 13888018
    [No Abstract]   [Full Text] [Related]  

  • 32. [Anticholinergic-meprobamate combination in the therapy of diseases of the digestive tract of psychosomatic nature].
    ROTTINI E; MARRI G; CALANDRA P
    Minerva Med; 1962 Jun; 53():1756-60. PubMed ID: 14494481
    [No Abstract]   [Full Text] [Related]  

  • 33. [Apropos of the treatment of several patients with priamide in a department of internal pathology].
    LANGERON L; VINCENT G; DUHAMEL M
    J Sci Med Lille; 1960 May; 78():298-305. PubMed ID: 14413966
    [No Abstract]   [Full Text] [Related]  

  • 34. A clinical evaluation of an anticholinergic agent in a sustained-release dose form.
    HOCK CW
    Curr Ther Res Clin Exp; 1962 Jul; 4():363-9. PubMed ID: 13907921
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on a new anticholinergic substance with marked antisecretory effect.
    STEIGMANN F; PAMUKCU F; CHUNG KS
    Am J Gastroenterol; 1960 Jan; 33():109-16. PubMed ID: 13834074
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of chronic digestive dysfunctions with an entozyme compound tablet.
    KETY SS
    Am J Gastroenterol; 1960 Jan; 33():106-8. PubMed ID: 14408715
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutic value in digestive pathology of a new synthetic substance: 1,1-diphenyl-3-hexamethylene-iminopropane HCl or hexadiphane, associated with dglucitol (sorbitol)].
    GAUSSEN I
    Sem Hop Ther Paris; 1962 Jan; 38():32-3. PubMed ID: 13897304
    [No Abstract]   [Full Text] [Related]  

  • 38. [Note on the neuroleptic syndrome and the use of a corrective agent, orphenadrine hydrochloride (disipal)].
    BAILLY-SALIN P; BOULANGER JJ; DJEGHRI M; GIRARD R; NIQUE M
    Ann Med Psychol (Paris); 1961 Feb; 119(1)():355-61. PubMed ID: 13685991
    [No Abstract]   [Full Text] [Related]  

  • 39. [Results obtained with an antispasmodic and sedative with prolonged effect in gastroenterology].
    LETENDRE P; BELLEMARE H
    Union Med Can; 1960 Feb; 89():216-7. PubMed ID: 14416065
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical trial of hydroxyphenamate (Listica) in alcoholic patients.
    GOULDMAN C; LUNDE F; DAVIS J
    Dis Nerv Syst; 1961 Sep; 22(9)Suppl():44-6. PubMed ID: 13707512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.